Cross-border M&A, deal structuring, due diligence, and corporate finance strategies for mid-market and enterprise transactions.
Onsemi’s $7 billion acquisition of Synaptics, alongside EDF-KKR, Safran-Exail, and sponsor interest in Qiagen, signals a broad M&A rebound spanning strategics and private equity. This analysis outlines what CFOs, General Counsel, and M&A directors should prioritize in diligence, regulatory strategy, and integration planning.
Onsemi’s $7 billion acquisition of Synaptics, alongside EDF-KKR and Safran-Exail transactions, signals a record 2026 M&A cycle projected at $6.4 trillion globally. This analysis breaks down what capability-driven dealmaking and intensifying cross-border regulation mean for CFOs, General Counsel, and boards.
Morgan Stanley forecasts global M&A will reach a record $6.4 trillion in 2026, with landmark deals like Onsemi’s $7 billion Synaptics acquisition and PE interest in Qiagen signalling a broad-based dealmaking recovery. European CFOs and M&A Directors must act now to build regulatory readiness and execution capability before the competitive window narrows.
Palo Alto Networks’ reported $20B+ pursuit of CyberArk, Xero’s $3B acquisition of Melio, and BBVA’s contested Sabadell bid define a cross-border M&A market where regulatory complexity and strategic ambition are rising together. Decision-makers must integrate antitrust risk, synergy stress-testing, and integration planning earlier than ever in the deal cycle.
Morgan Stanley projects global M&A will reach a record $6.4 trillion in 2026, as landmark cross-border deals in energy, life sciences, and semiconductors redefine corporate portfolio strategy. Decision-makers must act now to align due diligence, regulatory readiness, and post-merger integration capabilities with the demands of this accelerating deal environment.
Cross-border M&A is accelerating sharply in 2025, with landmark deals in life sciences, semiconductors, and energy infrastructure setting the tone for what Morgan Stanley projects will be a record $6.4 trillion global deal market in 2026. CFOs, General Counsel, and M&A Directors must now treat regulatory complexity and integration readiness as first-order strategic priorities.
Three major transactions announced within 48 hours — KKR’s acquisition of EDF Power Solutions, Merck KGaA’s $11.3 billion Bio-Techne deal, and ON Semiconductor’s $7 billion Synaptics acquisition — signal a structural acceleration in cross-border M&A. European dealmakers face both significant opportunity and heightened regulatory and integration complexity.
The EU’s full-scale investigation into Mars’s $36 billion Kellanova acquisition redefines antitrust risk for large cross-border M&A deals. CFOs and M&A Directors must integrate regulatory strategy into deal structuring from term-sheet stage.
The EDF–KKR carve-out and Morgan Stanley’s $6.4 trillion M&A forecast for 2026 signal a structural shift in how corporates and private equity are repositioning capital globally. CFOs, General Counsel, and M&A Directors must act with urgency on portfolio review, regulatory sequencing, and integration readiness.
Spain’s M&A market contracted 45% in Q2 2025 to €15,684 million, with private equity activity falling to €1,795 million — a sharp slowdown that reflects broader European deal-making caution driven by valuation gaps, financing pressure, and regulatory complexity. Decision-makers should treat this environment as a call for disciplined deal strategy, not a signal to disengage.